Providing process and manufacture outsourcing services (CDMO) for the pharmaceutical industry. The main scope of services covers all chemistry-related aspects of process development and transformation raw materials and products from laboratory scale to commercialized scale, including process research, process development, process optimization, pilot production and large-scale production of intermediates and API starting materials.
DDA has partnered with the world’s leaders in Regulatory Starting Material (RSM) manufacturing. Our RSM partners maintain an outstanding FDA track record and maintains a client base that includes almost every major pharmaceutical company in the world. We provide the quality and regulatory compliance so as to ensure your RSM strategy will be successful supporting the clients needs spanning from earliest stages of preclinical to commercialization.